Skip to main content
Clinical Trials/JPRN-UMIN000018377
JPRN-UMIN000018377
Completed
未知

Selective Sentinel Lymph Node Dissection and a One-step Nucleic Acid Amplification Assay for the Identification of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer - Sentinel OSNA assay of the lateral pelvic region

Yokohama City University Medical Center0 sites30 target enrollmentJuly 22, 2015
ConditionsRectal cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
Rectal cancer
Sponsor
Yokohama City University Medical Center
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 22, 2015
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) History of severe drug hypersensitivity 2\) history of another malignancy within 5 years 3\) Severe concurrent disease such as poorly controlled hypertension, poorly controlled diabetes, interstitial pneumonia or pulmonary fibrosis, severe chronic pulmonary emphysema, heart failure, renal failure, hepatic failure. 4\) Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. Males who are currently attempting to produce a pregnancy 5\) Physician concludes that the patient's participation in this trial is inappropriate

Outcomes

Primary Outcomes

Not specified

Similar Trials